Health management app developer Livongo Health was valued at $800m as of 2018, and a range of corporate investors could exit in the offering.

Livongo Health, a US-based health management technology developer backed by corporates including Merck & Co, Microsoft and Blue Cross Blue Shield of Massachusetts, has filed for a $100m initial public offering. Founded in 2014, Livongo provides technology that helps patients live with chronic health conditions. Its offering, which initially focused on diabetes, combines blood glucose…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.